“We are excited to partner with U.S. veterinarians and producers in using proactive breeding systems to help improve production outcomes,” said Robert Joseph, CEO of Parnell.

“With more that 50 years of innovation experience, we understand the real-time, low-risk needs that producers in partnership with veterinarians have around increasing their herd’s reproductive productivity.”

With the approval of GONAbreed for use in reproductive synchronization programs, veterinarians and producers no longer have to use drugs and protocols that are not FDA-approved for reproduction purposes.

They can safely and effectively use GONAbreed in combination with estroPLAN in breeding programs including  “ovsynch” and cosynch”.

FDA’s approval of GONAbreed was based, in part, on two multi-site, placebo-controlled studies evaluating pregnancy rates in lactating dairy cows and beef cows.

Both studies demonstrated a significant increase in pregnancy rates versus placebo. No significant adverse effects from GONAbreed or estroPLAN were noted in the treated cows.